Seroatlas · Human Serome Atlas

CLDN18

Claudin-18

Also known as: CLD18_HUMAN, SFTPJ

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P56856
Gene
CLDN18
Ensembl
ENSG00000066405
Chromosome
3
Canonical length
261 aa
Protein class
Predicted membrane proteins
Subcellular location
Cell Junctions

OverviewNCBI Gene

This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. This gene is upregulated in patients with ulcerative colitis and highly overexpressed in infiltrating ductal adenocarcinomas. PKC/MAPK/AP-1 (protein kinase C/mitogen-activated protein kinase/activator protein-1) dependent pathway regulates the expression of this gene in gastric cells. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jun 2010]

Canonical amino-acid sequenceUniProt

261 residues, UniProt reviewed canonical sequence.

>P56856|CLDN18
     1  MSTTTCQVVA FLLSILGLAG CIAATGMDMW STQDLYDNPV TSVFQYEGLW RSCVRQSSGF
    61  TECRPYFTIL GLPAMLQAVR ALMIVGIVLG AIGLLVSIFA LKCIRIGSME DSAKANMTLT
   121  SGIMFIVSGL CAIAGVSVFA NMLVTNFWMS TANMYTGMGG MVQTVQTRYT FGAALFVGWV
   181  AGGLTLIGGV MMCIACRGLA PEETNYKAVS YHASGHSVAY KPGGFKASTG FGSNTKNKKI
   241  YDGGARTEDE VQSYPSKHDY V

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CLDN18 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
4
Mean surface accessibility (rSASA)
0.4
Highest tissue expression
684 nTPM

Expression across tissuesHPA

Tissue

  • stomach: 684 nTPM
  • lung: 238 nTPM
  • heart muscle: 9 nTPM
  • gallbladder: 3.1 nTPM
  • duodenum: 1.4 nTPM
  • testis: 1.2 nTPM

Single-cell type

  • foveolar cells: 2,381 nCPM
  • alveolar cells type 1: 871 nCPM
  • parietal cells: 753 nCPM
  • mucous neck cells: 610 nCPM
  • alveolar cells type 2: 489 nCPM
  • gastric chief cells: 401 nCPM

Immune cell

  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM
  • MAIT T-cell: 0 nTPM

Brain region

  • choroid plexus: 5.6 nTPM
  • cerebellum: 3.1 nTPM
  • medulla oblongata: 3.1 nTPM
  • midbrain: 3 nTPM
  • spinal cord: 2.6 nTPM
  • hypothalamus: 2.1 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CLDN18.

Disease | ImmuneIEDB

Conditions an epitope on CLDN18 was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.27
gnomAD pLI
0
gnomAD missense Z
0.61
DepMap mean gene effect
0.09
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 1% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CLDN18 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CLDN18 as an antibody target. Whether an autoantibody or antibody against CLDN18 could matter depends on whether native CLDN18 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CLDN18 is annotated at the cell surface, where native CLDN18 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label CLDN18 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CLDN18. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...